全球生物技術設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球生物技術儀器市場預計將從2025年的914.1億美元成長至2034年的1,397.5億美元，2026年至2034年的複合年成長率（CAGR）為4.83%。該市場正經歷強勁成長，主要得益於生命科學研究和生物製藥開發領域投資的不斷增加。生物技術儀器廣泛應用於基因體學、蛋白質體學、分子診斷和藥物研發等領域。對精準醫療和先進診斷技術日益成長的需求正顯著推動市場擴張。研究機構、製藥公司和醫療機構正在採用先進的分析儀器來提高研究的準確性，並加速全球科學發現。

技術進步和慢性病盛行率的上升是推動市場成長的主要因素。定序系統、層析法設備和聚合酵素鏈鎖反應(PCR) 設備等儀器在現代生物技術研究中正變得至關重要。政府對醫療創新投入的增加以及生物技術新創企業的擴張進一步強化了市場需求。此外，自動化和數位化實驗室技術的日益普及提高了工作流程效率，並促進了儀器在各個研究機構的廣泛應用。

隨著生物技術在醫學、農業和環境科學等領域的應用不斷拓展，市場未來的成長前景依然十分廣闊。人工智慧、生物資訊學和實驗室自動化技術的進步可望提昇科學研究能力，並提高分析精度。在新興市場，隨著醫療基礎設施的完善和科研投入的增加，生物技術的應用預計將進一步加速。隨著全球對個人化醫療和基因研究的關注度不斷提高，預計在預測期內，市場將穩定成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭動態以及主要參與者所採取的策略。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點，或針對特定細分市場的深入洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球生技設備市場：依產品類型分類

• 市場分析、洞察與預測
• 實驗室自動化設備（液體處理系統、自動進樣器、機器人樣品處理器等）
• 生命科學耗材（試劑和緩衝液、微孔盤和試管、微量吸管尖和過濾）
• 體外診斷設備（臨床化學分析儀、血液分析儀、免疫檢測平台、分子診斷系統）

第5章 全球生技設備市場：依通路分類

• 市場分析、洞察與預測
• 離線
• 線上

第6章 全球生技設備市場：依最終用戶分類

• 市場分析、洞察與預測
• 政府和學術機構
• 製藥和生物技術公司
• 醫院和醫療設施
• 合約研究和製造組織

第7章 全球生技設備市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Agilent Technologies
  • Azenta US Inc
  • Becton, Dickinson And Company
  • BioMerieux SA
  • Bio-Rad Laboratories Inc
  • Bruker Corporation
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Hamilton Company
  • Hudson Robotics
  • Illumina Inc
  • Promega Corporation
  • QIAGEN NV
  • Quest Diagnostics

The global biotechnology instruments market size is expected to reach USD 139.75 Billion in 2034 from USD 91.41 Billion in 2025, growing at a CAGR of 4.83 during 2026-2034.This market is experiencing strong growth driven by rising investments in life sciences research and biopharmaceutical development. Biotechnology instruments are widely used in genomics, proteomics, molecular diagnostics, and drug discovery applications. Increasing demand for precision medicine and advanced diagnostic technologies is significantly supporting market expansion. Research institutions, pharmaceutical companies, and healthcare organizations are adopting sophisticated analytical instruments to improve research accuracy and accelerate scientific discoveries worldwide.

Technological advancements and increasing prevalence of chronic diseases are major drivers contributing to market growth. Instruments such as sequencing systems, chromatography equipment, and polymerase chain reaction devices are becoming essential for modern biotechnology research. Rising government funding for healthcare innovation and expanding biotechnology startups are further strengthening market demand. In addition, growing adoption of automation and digital laboratory technologies is improving workflow efficiency and encouraging broader instrument utilization across research facilities.

Future growth opportunities for the market remain highly promising as biotechnology applications continue expanding across healthcare, agriculture, and environmental sciences. Advancements in artificial intelligence, bioinformatics, and laboratory automation are expected to transform research capabilities and improve analytical precision. Emerging markets are likely to witness increased adoption due to improving healthcare infrastructure and growing scientific research investments. As global focus on personalized medicine and genetic research intensifies, the market is projected to expand steadily over the forecast period.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Lab Automation Instruments (Liquid Handling Systems and More, Automated Plate Handlers, Robotic Sample Processors)
• Life Science Consumables (Reagents & Buffers, Microplates & Tubes, Pipette Tips & Filtration)
• IVD Instruments (Clinical Chemistry Analyzers, Hematology Analyzers, Immunoassay Platforms, Molecular Diagnostics Systems)

By Distribution Channel

• Offline
• Online

By End-User

• Government & Academic Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Healthcare Facilities
• Contract Research & Manufacturing Organizations

COMPANIES PROFILED

• Agilent Technologies, Azenta US Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche AG, Hamilton Company, Hudson Robotics, Illumina Inc., Promega Corporation, QIAGEN N.V., Quest Diagnostics

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOTECHNOLOGY INSTRUMENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Lab Automation Instruments (Liquid Handling Systems and More, Automated Plate Handlers, Robotic Sample Processors) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Life Science Consumables (Reagents & Buffers, Microplates & Tubes, Pipette Tips & Filtration) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. IVD Instruments (Clinical Chemistry Analyzers, Hematology Analyzers, Immunoassay Platforms, Molecular Diagnostics Systems) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOTECHNOLOGY INSTRUMENTS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Offline Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Online Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOTECHNOLOGY INSTRUMENTS MARKET: BY END-USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-user
• 6.2. Government & Academic Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hospitals & Healthcare Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Contract Research & Manufacturing Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOTECHNOLOGY INSTRUMENTS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product Type
  • 7.2.2 By Distribution Channel
  • 7.2.3 By End-user
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product Type
  • 7.3.2 By Distribution Channel
  • 7.3.3 By End-user
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product Type
  • 7.4.2 By Distribution Channel
  • 7.4.3 By End-user
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product Type
  • 7.5.2 By Distribution Channel
  • 7.5.3 By End-user
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product Type
  • 7.6.2 By Distribution Channel
  • 7.6.3 By End-user
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOTECHNOLOGY INSTRUMENTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Agilent Technologies
  • 9.2.2 Azenta US Inc
  • 9.2.3 Becton, Dickinson And Company
  • 9.2.4 BioMerieux SA
  • 9.2.5 Bio-Rad Laboratories Inc
  • 9.2.6 Bruker Corporation
  • 9.2.7 Danaher Corporation
  • 9.2.8 Eppendorf SE
  • 9.2.9 F. Hoffmann-La Roche AG
  • 9.2.10 Hamilton Company
  • 9.2.11 Hudson Robotics
  • 9.2.12 Illumina Inc
  • 9.2.13 Promega Corporation
  • 9.2.14 QIAGEN N.V
  • 9.2.15 Quest Diagnostics